Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults
Clinical trial NCT05405283 · UNKNOWN
Trial details
- NCT number
- NCT05405283
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-08
- Primary completion
- 2022-07-15
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.